The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 14, 2007
Filed:
Jan. 06, 2006
Thomas G. Spring, Highland Park, IL (US);
Elaine M. Brate, Grayslake, IL (US);
Shelley Holets-mccormack, Waukegan, IL (US);
Rajarathnam E. Reddy, Gurnee, IL (US);
Donald D. Johnson, Lindenhurst, IL (US);
Yon-yih Chen, Mundelein, IL (US);
You Pan, Libertyville, IL (US);
Thomas G. Spring, Highland Park, IL (US);
Elaine M. Brate, Grayslake, IL (US);
Shelley Holets-McCormack, Waukegan, IL (US);
Rajarathnam E. Reddy, Gurnee, IL (US);
Donald D. Johnson, Lindenhurst, IL (US);
Yon-Yih Chen, Mundelein, IL (US);
You Pan, Libertyville, IL (US);
Abbott Laboratories, Abbott Park, IL (US);
Abstract
Methods and kits for measurement of concentration of FK778 in a biological sample by means of an immunoassay, preferably a competitive immunoassay. In one aspect, the method and kit involve the use of (a) an antibody to FK778 conjugated to a label, e.g., an acridinium label, (b) an antibody to FK778 not conjugated to a label, (c) a solid phase containing an antibody to a first hapten, e.g., a fluorescein hapten, and (d) a bihapten comprising a first hapten and FK778 or an analogue of FK778, e.g., a bihapten comprising a fluorescein hapten and a FK778 hapten. In another aspect, the method and kit involve the use of (a) antibody to FK778, (b) a bihapten comprising FK778 or an analogue of FK778 and a first hapten, e.g., a bihapten comprising the fluorescein hapten and the hapten of FK778 or an analogue of FK778, and (c) a pretreatment reagent.